STAA Q4 2017 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q4 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$25M+12.3% YoY

Gross Profit

$17M69.9% margin

Operating Income

-$1M-5.1% margin

Net Income

-$138,000-0.6% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+5.9%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$1M

Stock-Based Comp.

$976,000

Balance Sheet

Total Assets

$68M

Total Liabilities

$25M

Stockholders' Equity

$43M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$22M	+12.3%
Gross Profit	$17M	$16M	+9.5%
Operating Income	-$1M	$1M	-200.3%
Net Income	-$138,000	-$166,000	+16.9%

Revenue Segments

Implantable Collamer Lenses

$19M75%

Intraocular Lenses

$4M18%

Other Surgical Products

$2M7%

Geographic Segments

Other Countries

$8M31%

CHINA

$6M26%

JAPAN

$5M18%

KOREA, REPUBLIC OF

$4M17%

UNITED STATES

$2M8%